Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Reduced Disclosure Framework

2 Feb 2016 07:00

RNS Number : 7160N
Plant Health Care PLC
02 February 2016
 

 

Plant Health Care plc

2 February 2016

 

("Plant Health Care" or the "Company")

Adoption of the reduced disclosure framework within Financial Reporting Standard (FRS) 102

Following the publication of FRS 100 'Application of Financial Reporting Requirements' by the Financial Reporting Council, Plant Health Care plc is required to change its accounting framework for its entity financial statements, which currently adopt UK GAAP. It is intended for the period ended 31 December 2015 and future years that the parent entity and group subsidiaries adopt FRS 102, which is based on International Financial Reporting Standards as adopted by the European Union. As part of the adoption of FRS 102, the parent entity and group subsidiaries intend to take advantage of the "Reduced Disclosure Framework" available within FRS 102. The reduced disclosure framework is not expected to give rise to any significant changes in disclosure.

Shareholder approval to adopt FRS102 is not required, however shareholders holding 5% or more of the issued share capital of the Company may object to the use of the reduced disclosures available within FRS 102. If you have any queries regarding the Company's adoption of FRS102 or would like to object to the use of the reduced disclosure framework in the Company's financial statements, please contact Jeffrey Hovey, the Company's Chief Financial Officer at its registered office (48 Chancery Lane, London WC2A 1JF) not later than 1 March 2016.

Further information is available at: www.planthealthcare.com or please contact:

 

Plant Health Care plc

Jeff Hovey, Chief Financial OfficerTel: +19199261600 (x101)

 

Liberum

Clayton Bush / Chris Clarke

Tel: +44 (0) 20 3100 2227

 

LHA

Ed McGregor / Jody BurfeningTel: +12128383777

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBFLLBQLFBBBV
Date   Source Headline
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement
9th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20227:00 amRNSNew Products Submitted for Regulatory Approval
28th Oct 20227:00 amRNSRegistration of Harpin in France
28th Oct 20227:00 amRNSNew distribution agreement with EDAF
27th Oct 20227:00 amRNSTrading Update
14th Oct 20225:11 pmRNSDirector/PDMR Shareholding
14th Oct 202210:39 amRNSDirector / PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
22nd Aug 20227:00 amRNSTrials agreement signed with Agrii UK
12th Aug 20227:00 amRNSGrant of Options
10th Aug 20225:04 pmRNSDirector/PDMR Shareholding
21st Jul 20222:41 pmRNSHolding(s) in Company
18th Jul 20227:02 amRNSInvestor Presentation
18th Jul 20227:00 amRNSPost-Close Trading Update
22nd Jun 202212:37 pmRNSResult of AGM
21st Jun 20227:00 amRNSCompletion of Nominated Adviser due diligence
20th Jun 20227:00 amRNSLong-term Harpin Production and Supply Agreement
6th Jun 20228:00 amRNSHolding(s) in Company
6th Jun 20228:00 amRNSHolding(s) in Company
1st Jun 20222:31 pmRNSDirector/PDMR Shareholding
25th May 20225:23 pmRNSHolding(s) in Company
23rd May 20227:30 amRNSAnnual Report & Accounts and Notice of AGM
23rd May 20227:00 amRNSNew distribution agreement with Nutrien
16th May 20227:00 amRNSHolding(s) in Company
12th May 20227:15 amRNSCEO appointment and Board changes
12th May 20227:00 amRNSResults for the year ended 31 December 2021
28th Apr 20227:00 amRNSChange of Adviser
21st Apr 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.